We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.
Claire has over 13 years' experience as an analyst specialising in equities and managed investments. Claire is the Lead analyst with respect to small cap research mandates at Independent Investment Research. Previously, she was employed at Aegis Equities Research and joined IIR when that business was sold to Morningstar. She has a Bachelor of Commerce with Distinction and a Grad Diploma in Accounting from Deakin University.